Found: 45
Select item for more details and to access through your institution.
Immunologic and Prognostic Factors Associated with Overall Survival Employing a Poxviral-based PSA Vaccine in Metastatic Castrate-resistant Prostate Cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 1, doi. 10.1007/s00262-009-0782-8
- By:
- Publication type:
- Article
Assessment of Aortoiliac Atherosclerotic Plaque on CT in Prostate Cancer Patients Undergoing Treatment.
- Published in:
- Tomography: A Journal for Imaging Research, 2022, v. 8, n. 2, p. 607, doi. 10.3390/tomography8020050
- By:
- Publication type:
- Article
A phase I study of TRC105 anti-endoglin ( CD105) antibody in metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2015, v. 116, n. 4, p. 546, doi. 10.1111/bju.12986
- By:
- Publication type:
- Article
American Cancer Society's report on the status of cancer disparities in the United States, 2023.
- Published in:
- CA: A Cancer Journal for Clinicians, 2024, v. 74, n. 2, p. 136, doi. 10.3322/caac.21812
- By:
- Publication type:
- Article
Screening for lung cancer: 2023 guideline update from the American Cancer Society.
- Published in:
- CA: A Cancer Journal for Clinicians, 2024, v. 74, n. 1, p. 50, doi. 10.3322/caac.21811
- By:
- Publication type:
- Article
The future of cancer care at home: Findings from an American Cancer Society summit.
- Published in:
- 2023
- By:
- Publication type:
- Proceeding
Androgen Deprivation Therapy for Prostate Cancer.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 294, n. 2, p. 238, doi. 10.1001/jama.294.2.238
- By:
- Publication type:
- Article
Cabazitaxel: a new drug for metastatic prostate cancer.
- Published in:
- Asian Journal of Andrology, 2011, v. 13, n. 2, p. 185, doi. 10.1038/aja.2010.161
- By:
- Publication type:
- Article
Is It Time to Reevaluate Definitive Therapy in Prostate Cancer?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 10, p. 683, doi. 10.1093/jnci/djt094
- By:
- Publication type:
- Article
A tripartite approach toward ending cancer as we know it, for everyone: An American Cancer Society perspective.
- Published in:
- Journal of Surgical Oncology, 2023, v. 128, n. 6, p. 931, doi. 10.1002/jso.27463
- By:
- Publication type:
- Article
Sorafenib-Induced Eruption Mimicking Erythema Multiforme.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 2, p. 170, doi. 10.1001/jamadermatol.2014.2734
- By:
- Publication type:
- Article
Predicting Outcomes of Indeterminate Bone Lesions on <sup>18</sup>F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 395, doi. 10.2967/jnumed.122.264334
- By:
- Publication type:
- Article
Predicting Outcomes of Indeterminate Bone Lesions on <sup>18</sup>F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264334
- By:
- Publication type:
- Article
A comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262371
- By:
- Publication type:
- Article
A comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262371
- By:
- Publication type:
- Article
A comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262371
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F-NaF PET: A Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 12, p. 1872, doi. 10.2967/jnumed.116.177295
- By:
- Publication type:
- Article
Prospective Study Evaluating Na<sup>18</sup>F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 6, p. 886, doi. 10.2967/jnumed.115.166512
- By:
- Publication type:
- Article
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 642, doi. 10.1093/oncolo/oyad058
- By:
- Publication type:
- Article
Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression.
- Published in:
- Oncologist, 2010, v. 15, n. 9, p. 969, doi. 10.1634/theoncologist.2010-0129
- By:
- Publication type:
- Article
Osteonecrosis of the Jaw and the Use of Antiangiogenic Agents: Just an Association?
- Published in:
- 2008
- By:
- Publication type:
- Letter
Acute aortic dissection in a hypertensive patient with prostate cancer undergoing chemotherapy containing bevacizumab.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 8, p. 1600, doi. 10.1080/02841860801978905
- By:
- Publication type:
- Article
The use of bisphosphonates in cancer patients.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 5, p. 581, doi. 10.1080/02841860701233435
- By:
- Publication type:
- Article
Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate-resistant prostate cancer.
- Published in:
- Stem Cells, 2024, v. 42, n. 6, p. 526, doi. 10.1093/stmcls/sxae025
- By:
- Publication type:
- Article
Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2013, v. 111, n. 8, p. 1269, doi. 10.1111/j.1464-410X.2012.11667.x
- By:
- Publication type:
- Article
HEPCIDIN, ANAEMIA, AND PROSTATE CANCER.
- Published in:
- BJU International, 2011, v. 107, n. 4, p. 678, doi. 10.1111/j.1464-410X.2011.10108.x
- By:
- Publication type:
- Article
Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2009, v. 103, n. 12, p. 1636, doi. 10.1111/j.1464-410X.2008.08327.x
- By:
- Publication type:
- Article
Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.
- Published in:
- BJU International, 2008, v. 102, n. 11, p. 1694, doi. 10.1111/j.1464-410X.2008.07913.x
- By:
- Publication type:
- Article
A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer.
- Published in:
- BJU International, 2008, v. 102, n. 5, p. 617, doi. 10.1111/j.1464-410X.2008.07629.x
- By:
- Publication type:
- Article
Secondary hormonal therapy for prostate cancer: what lies on the horizon?
- Published in:
- BJU International, 2008, v. 101, n. 3, p. 271, doi. 10.1111/j.1464-410X.2007.07236.x
- By:
- Publication type:
- Article
Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancer.
- Published in:
- BJU International, 2007, v. 100, n. 6, p. 1245, doi. 10.1111/j.1464-410X.2007.07173.x
- By:
- Publication type:
- Article
Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone.
- Published in:
- BJU International, 2007, v. 99, n. 3, p. 525, doi. 10.1111/j.1464-410X.2006.06654.x
- By:
- Publication type:
- Article
A retrospective study of the time to clinical endpoints for advanced prostate cancer.
- Published in:
- BJU International, 2005, v. 96, n. 7, p. 985, doi. 10.1111/j.1464-410X.2005.05798.x
- By:
- Publication type:
- Article
Increased Frequency of Venous Thromboembolism with the Combination of Docetaxel and Thalidomide in Patients with Metastatic Androgen-Independent Prostate Cancer.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 3, p. 315
- By:
- Publication type:
- Article
Population pharmacokinetic analysis of sorafenib in patients with solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 294, doi. 10.1111/j.1365-2125.2011.03963.x
- By:
- Publication type:
- Article
Angiogenesis Inhibition in Prostate Cancer: Current Uses and Future Promises.
- Published in:
- Journal of Oncology, 2010, p. 1, doi. 10.1155/2010/361836
- By:
- Publication type:
- Article
Reversal of Docetaxel Resistance With Bevacizumab and Thalidomide.
- Published in:
- Clinical Genitourinary Cancer, 2009, v. 7, n. 2, p. E37, doi. 10.3816/CGC.2009.n.020
- By:
- Publication type:
- Article
A case report of multiple primary prostate tumors with differential drug sensitivity.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14657-7
- By:
- Publication type:
- Article
Management Options for Biochemically Recurrent Prostate Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2010, v. 29, p. 95, doi. 10.1186/1756-9966-29-95
- By:
- Publication type:
- Article
Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 6, p. 650, doi. 10.1177/0091270009335001
- By:
- Publication type:
- Article
Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 6, p. 650, doi. 10.1177/0091270009335001
- By:
- Publication type:
- Article
A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.00490
- By:
- Publication type:
- Article
Determination of 2-methoxyestradiol in human plasma, using liquid chromatography/tandem mass spectrometry.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2005, v. 19, n. 9, p. 1176, doi. 10.1002/rcm.1902
- By:
- Publication type:
- Article